SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS
The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CASAUBON, Rebecca DISCH, Jeremy S KOPPETSCH, Karsten PERNI, Robert, B NG, Pui, Yee BLUM, Charles A SZCZEPANKIEWICZ, Bruce G CALDWELL, Richard Dana MILLER, William, Henry OALMANN, Christopher FOX, Ryan Michael WHITE, Brian H |
| description | The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3221312A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3221312A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3221312A23</originalsourceid><addsrcrecordid>eNrjZDALDnUKDvEMCQ1xdVFwCvJ0cQfSoUGujgqOfo4-_u7BCo7BCsGeQSGhnn4Kvv4uoT6OIf5BwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wNjIyNDY0MjRyJgIJQDjFCey</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS</title><source>esp@cenet</source><creator>CASAUBON, Rebecca ; DISCH, Jeremy S ; KOPPETSCH, Karsten ; PERNI, Robert, B ; NG, Pui, Yee ; BLUM, Charles A ; SZCZEPANKIEWICZ, Bruce G ; CALDWELL, Richard Dana ; MILLER, William, Henry ; OALMANN, Christopher ; FOX, Ryan Michael ; WHITE, Brian H</creator><creatorcontrib>CASAUBON, Rebecca ; DISCH, Jeremy S ; KOPPETSCH, Karsten ; PERNI, Robert, B ; NG, Pui, Yee ; BLUM, Charles A ; SZCZEPANKIEWICZ, Bruce G ; CALDWELL, Richard Dana ; MILLER, William, Henry ; OALMANN, Christopher ; FOX, Ryan Michael ; WHITE, Brian H</creatorcontrib><description>The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170927&DB=EPODOC&CC=EP&NR=3221312A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170927&DB=EPODOC&CC=EP&NR=3221312A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CASAUBON, Rebecca</creatorcontrib><creatorcontrib>DISCH, Jeremy S</creatorcontrib><creatorcontrib>KOPPETSCH, Karsten</creatorcontrib><creatorcontrib>PERNI, Robert, B</creatorcontrib><creatorcontrib>NG, Pui, Yee</creatorcontrib><creatorcontrib>BLUM, Charles A</creatorcontrib><creatorcontrib>SZCZEPANKIEWICZ, Bruce G</creatorcontrib><creatorcontrib>CALDWELL, Richard Dana</creatorcontrib><creatorcontrib>MILLER, William, Henry</creatorcontrib><creatorcontrib>OALMANN, Christopher</creatorcontrib><creatorcontrib>FOX, Ryan Michael</creatorcontrib><creatorcontrib>WHITE, Brian H</creatorcontrib><title>SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS</title><description>The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDALDnUKDvEMCQ1xdVFwCvJ0cQfSoUGujgqOfo4-_u7BCo7BCsGeQSGhnn4Kvv4uoT6OIf5BwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wNjIyNDY0MjRyJgIJQDjFCey</recordid><startdate>20170927</startdate><enddate>20170927</enddate><creator>CASAUBON, Rebecca</creator><creator>DISCH, Jeremy S</creator><creator>KOPPETSCH, Karsten</creator><creator>PERNI, Robert, B</creator><creator>NG, Pui, Yee</creator><creator>BLUM, Charles A</creator><creator>SZCZEPANKIEWICZ, Bruce G</creator><creator>CALDWELL, Richard Dana</creator><creator>MILLER, William, Henry</creator><creator>OALMANN, Christopher</creator><creator>FOX, Ryan Michael</creator><creator>WHITE, Brian H</creator><scope>EVB</scope></search><sort><creationdate>20170927</creationdate><title>SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS</title><author>CASAUBON, Rebecca ; DISCH, Jeremy S ; KOPPETSCH, Karsten ; PERNI, Robert, B ; NG, Pui, Yee ; BLUM, Charles A ; SZCZEPANKIEWICZ, Bruce G ; CALDWELL, Richard Dana ; MILLER, William, Henry ; OALMANN, Christopher ; FOX, Ryan Michael ; WHITE, Brian H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3221312A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>CASAUBON, Rebecca</creatorcontrib><creatorcontrib>DISCH, Jeremy S</creatorcontrib><creatorcontrib>KOPPETSCH, Karsten</creatorcontrib><creatorcontrib>PERNI, Robert, B</creatorcontrib><creatorcontrib>NG, Pui, Yee</creatorcontrib><creatorcontrib>BLUM, Charles A</creatorcontrib><creatorcontrib>SZCZEPANKIEWICZ, Bruce G</creatorcontrib><creatorcontrib>CALDWELL, Richard Dana</creatorcontrib><creatorcontrib>MILLER, William, Henry</creatorcontrib><creatorcontrib>OALMANN, Christopher</creatorcontrib><creatorcontrib>FOX, Ryan Michael</creatorcontrib><creatorcontrib>WHITE, Brian H</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CASAUBON, Rebecca</au><au>DISCH, Jeremy S</au><au>KOPPETSCH, Karsten</au><au>PERNI, Robert, B</au><au>NG, Pui, Yee</au><au>BLUM, Charles A</au><au>SZCZEPANKIEWICZ, Bruce G</au><au>CALDWELL, Richard Dana</au><au>MILLER, William, Henry</au><au>OALMANN, Christopher</au><au>FOX, Ryan Michael</au><au>WHITE, Brian H</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS</title><date>2017-09-27</date><risdate>2017</risdate><abstract>The present invention relates to novel substituted bridged urea compounds, corresponding related analogs, pharmaceutical compositions and methods of use thereof. Sirtuin-modulating compounds of the present invention may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders, which include, but are not limited to, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. The present invention also related to compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3221312A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | SUBSTITUTED BRIDGED UREA ANALOGS AS SIRTUIN MODULATORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T18%3A16%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CASAUBON,%20Rebecca&rft.date=2017-09-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3221312A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |